Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Leonard Frank X Create: Alert

All | News | Filings
Date FiledTypeDescription
03/07/2023 4 Leonard Frank X (President, CNS Cancers US) has filed a Form 4 on NovoCure Ltd
Txns: Sold 4,403 shares @ $76.1594, valued at $335.3k
Sold 888 shares @ $76.1594, valued at $67.6k
Sold 6,003 shares @ $74.9968, valued at $450.2k
Sold 2,315 shares @ $75.5937, valued at $175k
03/06/2023 4 Leonard Frank X (President, CNS Cancers US) has filed a Form 4 on NovoCure Ltd
Txns: Sold 844 shares @ $75.2779, valued at $63.5k
Granted 11,808 shares @ $0
Sold 2,059 shares @ $77.6391, valued at $159.9k
03/02/2023 4 Leonard Frank X (President, CNS Cancers US) has filed a Form 4 on NovoCure Ltd
Txns: Granted 18,621 shares @ $0
Sold 1,684 shares @ $76.3624, valued at $128.6k
Granted 30,971 options to buy @ $76.97, valued at $2.4M
01/09/2023 4 Leonard Frank X (President, CNS Cancers US) has filed a Form 4 on NovoCure Ltd
Txns: Sold 2,345 shares @ $119.0077, valued at $279.1k
Sold 417 shares @ $108, valued at $45k
Sold 526 shares @ $115.0348, valued at $60.5k
Sold 1,010 shares @ $117, valued at $118.2k
Sold 7,826 shares @ $108, valued at $845.2k
Sold 7,500 shares @ $108, valued at $810k
Sold 5,517 shares @ $108, valued at $595.8k
Sold 7,183 shares @ $114.0001, valued at $818.9k
Sold 7,183 shares @ $120, valued at $862k
Exercised 7,826 options to buy @ $14.37, valued at $112.5k
Exercised 7,500 options to buy @ $11.46, valued at $86k
11/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/17/2022 4 Leonard Frank X (President, CNS Cancers US) has filed a Form 4 on NovoCure Ltd
Txns: Sold 6,754 shares @ $76.01, valued at $513.4k
10/07/2022 4 Leonard Frank X (President, CNS Cancers US) has filed a Form 4 on NovoCure Ltd
Txns: Sold 6,754 shares @ $84.37, valued at $569.8k
09/30/2022 4 Leonard Frank X (President, CNS Cancers US) has filed a Form 4 on NovoCure Ltd
Txns: Sold 6,754 shares @ $77.35, valued at $522.4k
09/26/2022 4 Leonard Frank X (President, CNS Cancers US) has filed a Form 4 on NovoCure Ltd
Txns: Sold 6,754 shares @ $77, valued at $520.1k
09/19/2022 4 Leonard Frank X (Chief Development Officer) has filed a Form 4 on NovoCure Ltd
Txns: Sold 6,754 shares @ $87.31, valued at $589.7k
Sold 5,517 shares @ $90, valued at $496.5k
Exercised 5,517 options to buy @ $7.15, valued at $39.4k
09/13/2022 4/A Leonard Frank X (Chief Development Officer) has filed a Form 4 on NovoCure Ltd
Txns: Sold 6,754 shares @ $81.48, valued at $550.3k
09/12/2022 4 Leonard Frank X (Chief Development Officer) has filed a Form 4 on NovoCure Ltd
Txns: Sold 1,863 shares @ $88, valued at $163.9k
09/07/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/07/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/07/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/07/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/04/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/08/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/10/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/08/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/04/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/10/2020 3 Leonard Frank X (Chief Development Officer) has filed a Form 3 on NovoCure Ltd
09/04/2020 4 Leonard Frank X (Chief Development Officer) has filed a Form 4 on NovoCure Ltd
Txns: Granted 5,904 shares @ $0
Granted 11,336 options to buy @ $84.68, valued at $959.9k

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy